Envoy Medical Debt to Equity Ratio 2021-2026 | COCH
Current and historical debt to equity ratio values for Envoy Medical (COCH) over the last 10 years. The debt/equity ratio can be defined as a measure of a company's financial leverage calculated by dividing its long-term debt by stockholders' equity. Envoy Medical debt/equity for the three months ending June 30, 2026 was 0.00.
| Envoy Medical Debt/Equity Ratio Historical Data | |||
|---|---|---|---|
| Date | Long Term Debt | Shareholder's Equity | Debt to Equity Ratio |
| 2026-06-30 | $0.02B | $0.00B | 6.25 |
| 2026-03-31 | $0.02B | $0.01B | 1.94 |
| 2025-12-31 | $0.02B | $-0.01B | -1.70 |
| 2025-09-30 | $0.02B | $-0.01B | -2.07 |
| 2025-06-30 | $0.04B | $-0.03B | -1.33 |
| 2025-03-31 | $0.04B | $-0.02B | -1.43 |
| 2024-12-31 | $0.03B | $-0.02B | -1.61 |
| 2024-09-30 | $0.03B | $-0.02B | -1.51 |
| 2024-06-30 | $0.02B | $-0.01B | -1.54 |
| 2024-03-31 | $0.02B | $-0.01B | -2.14 |
| 2023-12-31 | $0.01B | $0.00B | -5.66 |
| 2023-09-30 | $0.02B | $0.01B | 3.43 |
| 2023-06-30 | $0.07B | $-0.02B | -3.17 |
| 2023-03-31 | $0.07B | $-0.02B | -3.39 |
| 2022-12-31 | $0.04B | $-0.04B | -1.07 |
| 2022-09-30 | $0.45B | $-0.02B | -25.66 |
| 2022-06-30 | $0.45B | $-0.02B | -20.91 |
| 2022-03-31 | $0.45B | $-0.02B | -18.58 |
| 2021-12-31 | $0.46B | $-0.04B | -12.63 |
| 2021-09-30 | $0.46B | $-0.03B | -14.03 |
| 2021-06-30 | $0.42B | $0.01B | 84.57 |
| 2021-03-31 | $0.42B | $0.01B | 83.66 |
| 2020-12-31 | $0.00B | 0.00 | |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Instruments Manufacturing | $0.055B | $0.000B |
| Envoy Medical Inc. is a medical technology company focused on fully implanted hearing devices. The company's primary device is the fully implanted Acclaim(R) cochlear implant. Envoy Medical Inc., formerly known as Anzu Special Acquisition Corp I, is headquartered in White Bear Lake, Minnesota. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Thermo Fisher Scientific (TMO) | United States | $237.152B | 26.92 |
| Intuitive Surgical (ISRG) | United States | $133.242B | 45.17 |
| Edwards Lifesciences (EW) | United States | $49.369B | 30.51 |
| IQVIA Holdings (IQV) | United States | $44.388B | 23.74 |
| Waters (WAT) | United States | $40.978B | 30.49 |
| IDEXX Laboratories (IDXX) | United States | $40.236B | 35.92 |
| Alcon (ALC) | Switzerland | $33.515B | 20.78 |
| DexCom (DXCM) | United States | $32.623B | 33.90 |
| Mettler-Toledo (MTD) | United States | $26.657B | 29.64 |
| STERIS (STE) | Ireland | $20.502B | 20.18 |
| Hologic (HOLX) | United States | $16.752B | 17.53 |
| SONOVA HOLDING (SONVY) | Switzerland | $16.610B | 0.00 |
| Coloplast (CLPBY) | Denmark | $14.694B | 17.62 |
| Penumbra (PEN) | United States | $12.543B | 82.71 |
| Fresenius Medical Care AG KGaA (FMS) | Germany | $12.332B | 8.63 |
| Glaukos (GKOS) | United States | $10.126B | 0.00 |
| Globus Medical (GMED) | United States | $10.028B | 15.18 |
| Masimo (MASI) | United States | $9.578B | 30.69 |
| SARTORIUS (SSSGY) | Germany | $7.521B | 43.67 |
| Sysmex ADR (SSMXY) | Japan | $7.442B | 28.15 |
| Teleflex (TFX) | United States | $5.467B | 14.74 |
| LivaNova (LIVN) | United Kingdom | $4.378B | 22.14 |
| Integer Holdings (ITGR) | United States | $4.291B | 19.88 |
| Pulse Biosciences (PLSE) | United States | $3.820B | 0.00 |
| Veracyte (VCYT) | United States | $3.227B | 26.41 |
| TransMedics (TMDX) | United States | $3.044B | 44.72 |
| AxoGen (AXGN) | United States | $2.418B | 0.00 |
| UFP Technologies (UFPT) | United States | $2.134B | 26.93 |
| Elekta AB (EKTAY) | Sweden | $1.948B | 18.22 |
| Nihon Kohden (NHNKY) | Japan | $1.688B | 15.46 |
| Alphatec Holdings (ATEC) | United States | $1.646B | 0.00 |
| Alpha Tau Medical (DRTS) | Israel | $1.343B | 0.00 |
| Artivion (AORT) | United States | $1.237B | 47.00 |
| Integra LifeSciences Holdings (IART) | United States | $1.220B | 6.35 |
| OPKO Health (OPK) | United States | $1.172B | 0.00 |
| AVANOS MEDICAL, INC (AVNS) | United States | $1.171B | 27.77 |
| Tandem Diabetes Care (TNDM) | United States | $1.133B | 0.00 |
| PROCEPT BioRobotics (PRCT) | United States | $1.105B | 0.00 |
| IRadimed (IRMD) | United States | $1.054B | 46.04 |
| Beta Bionics (BBNX) | United States | $0.865B | 0.00 |
| SiBone (SIBN) | United States | $0.823B | 0.00 |
| Anteris Technologies Global (AVR) | Australia | $0.813B | 0.00 |
| Mesa Laboratories (MLAB) | United States | $0.712B | 17.14 |
| AngioDynamics (ANGO) | United States | $0.648B | 0.00 |
| OrthoPediatrics (KIDS) | United States | $0.607B | 0.00 |
| Delcath Systems (DCTH) | United States | $0.561B | 1617.00 |
| Tactile Systems Technology (TCMD) | United States | $0.510B | 20.84 |
| NeuroPace (NPCE) | United States | $0.489B | 0.00 |
| Sight Sciences (SGHT) | United States | $0.447B | 0.00 |
| Pacific Biosciences Of California (PACB) | United States | $0.417B | 0.00 |
| 908 Devices (MASS) | United States | $0.412B | 0.00 |
| ClearPoint Neuro (CLPT) | United States | $0.401B | 0.00 |
| ORTHOFIX MEDICAL INC (OFIX) | United States | $0.370B | 0.00 |
| Mobia Medical (MOBI) | United States | $0.359B | 0.00 |
| Semler Scientific (SMLR) | United States | $0.311B | 2.32 |
| Treace Medical Concepts (TMCI) | United States | $0.298B | 0.00 |
| Spectral Diagnostics (EDTXF) | Canada | $0.266B | 0.00 |
| RxSight (RXST) | United States | $0.234B | 0.00 |
| Neuronetics (STIM) | United States | $0.213B | 0.00 |
| Lucid Diagnostics (LUCD) | United States | $0.161B | 0.00 |
| FocalTherics (FOCL) | France | $0.153B | 0.00 |
| Inogen (INGN) | United States | $0.138B | 0.00 |
| EDAP TMS S.A (EDAP) | France | $0.124B | 0.00 |
| Microbot Medical (MBOT) | United States | $0.097B | 0.00 |
| LENSAR (LNSR) | United States | $0.094B | 0.00 |
| Hyperfine (HYPR) | United States | $0.085B | 0.00 |
| Zomedica (ZOMDF) | United States | $0.082B | 0.00 |
| CVRx (CVRX) | United States | $0.080B | 0.00 |
| QT Imaging Holdings (QTIH) | United States | $0.078B | 0.00 |
| Covalon Technologies (CVALF) | Canada | $0.070B | 23.00 |
| DarioHealth (DRIO) | United States | $0.066B | 0.00 |
| Positron (POSC) | United States | $0.058B | 0.00 |
| Rapid Micro Biosystems (RPID) | United States | $0.058B | 0.00 |
| Nano-X Imaging (NNOX) | Israel | $0.054B | 0.00 |
| Vaso (VASO) | United States | $0.051B | 29.09 |
| Spectral AI (MDAI) | United States | $0.051B | 0.00 |
| Sensus Healthcare (SRTS) | United States | $0.051B | 0.00 |
| Precision Optics (POCI) | United States | $0.046B | 0.00 |
| Baird Medical Investment Holdings (BDMD) | $0.045B | 0.00 | |
| InspireMD (NSPR) | United States | $0.036B | 0.00 |
| QT Imaging Holdings (QTI) | United States | $0.035B | 0.00 |
| Ekso Bionics Holdings (EKSO) | United States | $0.032B | 0.00 |
| PAVmed (PAVM) | United States | $0.031B | 0.00 |
| Accuray (ARAY) | United States | $0.028B | 0.00 |
| Adagio Medical Holdings (ADGM) | United States | $0.010B | 0.00 |
| ENDRA Life Sciences (NDRA) | United States | $0.008B | 0.00 |
| EnVVeno Medical (NVNO) | United States | $0.006B | 0.00 |
| Nanovibronix (NAOV) | United States | $0.004B | 0.00 |
| Autonomix Medical (AMIX) | United States | $0.004B | 0.00 |
| Bluejay Diagnostics (BJDX) | United States | $0.004B | 0.00 |
| Tenon Medical (TNON) | United States | $0.003B | 0.00 |
| Nuwellis (NUWE) | United States | $0.003B | 0.00 |
| NexGel (NXGL) | United States | $0.003B | 0.00 |
| ENvue Medical (FEED) | United States | $0.001B | 0.00 |
| Inspira Technologies OXY B.H.N (IINN) | Israel | $0.000B | 0.00 |
| Longview Acquisition II (LGV) | United States | $0.000B | 0.00 |
| Spinal Elements Holdings (SPEL) | United States | $0.000B | 0.00 |
| WORK Medical Technology Group (WOK) | China | $0.000B | 0.00 |
| SINTX TECHNOLOGIES, INC (SINT) | United States | $0.000B | 0.00 |